Longtime Pfizer R&D chief Kathy Fernando, Ph.D., has left the Big Pharma behind to take on the role of chief business officer at San Diego biotech Replicate Bioscience. There, she’ll work to advance ...

This article was commissioned in conjunction with the Professors’ Programme, part of Prototypes for Humanity, a global initiative that showcases and accelerates academic innovation to solve social and ...

Qlik, a data integration, data quality, analytics, and artificial intelligence (AI) solutions provider, today previewed its new agentic experience in Qlik Cloud delivered through Qlik Answers as the ...

Cloudflare Inc. has acquired Replicate Inc., a startup with software that makes it easier to deploy artificial intelligence models in production. The companies announced the transaction today without ...

Cloudflare (NET) announced it has reached an agreement to acquire Replicate, which will give developers on its Workers platform access to tens of thousands of artificial intelligence models. Replicate ...

(RTTNews) - Cloudflare, Inc. (NET), Monday announced its decision to acquire Replicate, an AI platform, enabling quick and easy deployment of any AI model to millions of Cloudflare users worldwide.

Qlik announced the rapid adoption of Qlik Predict, a no-code predictive analytics platform designed for business users. The solution, announced Oct. 1, aims to transform how organizations leverage ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

Lately, there’s been this growing idea that technology might one day take over roles like therapist, teacher, coach, or even doctor. Sure, it’s getting pretty good at things like organizing ...

Aug 28 (Reuters) - Replicate Bioscience will partner with Novo Nordisk (NOVOb.CO), opens new tab to develop treatments using self-replicating RNA technology for obesity, type 2 diabetes and other ...

Novo Nordisk has both internal research and external alliances pursuing new drugs that could shape the next generation of metabolic medicines. The pharmaceutical giant’s latest move is a partnership ...

As obesity pioneer Novo Nordisk loses ground in the race for next-generation drugs, the Danish pharma giant is betting on novel RNA technology to bolster its early-stage pipeline. Novo has inked a ...